Rating Change
Barclays reiterated its Equal-Weight rating on Alignment Healthcare, Inc. (NASDAQ:ALHC) on October 06, 2026.
Barclays reiterated its Equal-Weight rating on Alignment Healthcare, Inc. (NASDAQ:ALHC) on October 06, 2026.

At publication ·
Alignment Healthcare, Inc. (NASDAQ:ALHC) · reiterate
At a glance
Barclays reiterated its Equal-Weight rating on Alignment Healthcare, Inc. (NASDAQ:ALHC) on October 06, 2026.
Alignment Healthcare, Inc. operates in the Healthcare sector. The stock currently trades at $8.37 with a market capitalization of $3.8B.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Alignment Healthcare, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 5 Buy, 5 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 06, 2026 | Barclays | Equal-Weight | N/A |
| Aug 04, 2026 | JP Morgan | Overweight | N/A |
| Aug 03, 2026 | Raymond James | Outperform | N/A |
| May 26, 2026 | Barclays | Equal-Weight | N/A |
| May 01, 2026 | UBS | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View ALHC Stock Page
A rating of Equal-Weight from Barclays reflects the analyst's outlook on Alignment Healthcare, Inc. (NASDAQ:ALHC). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ALHC forecast page.
Current market data
NASDAQ · ALHC
$7.55
Down: -$1.17 · -13.38%
Live quote updated
Keep reading
sec_filing ·
analyst ·
analyst ·
earnings ·